HAZRX Trademark

Trademark Overview

On Tuesday, October 24, 2017, a trademark application was filed for HAZRX with the United States Patent and Trademark Office. The USPTO has given the HAZRX trademark a serial number of 87657531. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, June 5, 2024. This trademark is owned by United States Pharmacopeial Convention. The HAZRX trademark is filed in the Computer & Software Products & Electrical & Scientific Products category with the following description:

Downloadable software in the nature of a mobile application for accessing medical and scientific information related to the safe handling of hazardous drugs in healthcare settings
hazrx

General Information

Serial Number87657531
Word MarkHAZRX
Filing DateTuesday, October 24, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, June 5, 2024
Registration Number5613343
Registration DateTuesday, November 20, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 10, 2018

Trademark Statements

Goods and ServicesDownloadable software in the nature of a mobile application for accessing medical and scientific information related to the safe handling of hazardous drugs in healthcare settings

Classification Information

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateThursday, November 2, 2017
Primary Code009
First Use Anywhere DateThursday, February 1, 2018
First Use In Commerce DateThursday, February 1, 2018

Trademark Owner History

Party NameUnited States Pharmacopeial Convention
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20852
Party NameUnited States Pharmacopeial Convention
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20852
Party NameUnited States Pharmacopeial Convention
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20852

Trademark Events

Event DateEvent Description
Wednesday, February 7, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 27, 2017NEW APPLICATION ENTERED
Thursday, November 2, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 2, 2018ASSIGNED TO EXAMINER
Wednesday, February 7, 2018NON-FINAL ACTION E-MAILED
Wednesday, February 7, 2018NON-FINAL ACTION WRITTEN
Tuesday, February 13, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 13, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 13, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 7, 2018ASSIGNED TO LIE
Tuesday, February 27, 2018EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 27, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, February 27, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, February 27, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, February 28, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 12, 2018SU - NON-FINAL ACTION - WRITTEN
Thursday, July 12, 2018NON-FINAL ACTION E-MAILED
Wednesday, March 21, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 10, 2018PUBLISHED FOR OPPOSITION
Tuesday, April 10, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 5, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 13, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, June 13, 2018USE AMENDMENT FILED
Monday, July 9, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 9, 2018STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 12, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 10, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 19, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 26, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 26, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 27, 2018SU - FINAL REFUSAL - WRITTEN
Thursday, September 27, 2018FINAL REFUSAL E-MAILED
Thursday, September 27, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, October 2, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, October 10, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 20, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, November 29, 2023TEAS SECTION 8 & 15 RECEIVED
Wednesday, June 5, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 5, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, June 5, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, November 20, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, October 18, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, October 19, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

hazrx handling safe related hazardous drugs settings healthcare information scientific nature